22nd IMS Annual Meeting

The International Myeloma Society Meeting is the defining annual meeting in myeloma with a focus on both the basic, preclinical, and clinical aspects. This year’s program includes: Four thematic sessions on: Precursor Disease Risk Adaptation Management Immunotherapy Relapse within 1-3 lines of therapy Talks and symposia on pressing topics led by the KOL of the myeloma community Keynote addresses Joint sessions with regulatory agencies and other organisations Meet the Expert sessions Oral Abstracts (on Basic Biology, Preclinical Trials, and Clinical Studies) Poster presentations and discussion sessions